European Union - Commission clears acquisition of anial health assets of Pfizer by Eli Lilly&Co
http://europa.eu/rapid/pressReleasesAction.do?reference=MEX/10/0525&format=HTML&aged=0&language=EN&guiLanguage=ca
27-May-2010 (16 years 12 days ago)The European Commission has granted clearance under the EU Merger Regulation to the acquisition of animal health assets of Pfizer by Eli Liily & Co, both of the USA.
Eli Lilly is a research based, global pharmaceutical company engaged in the discovery, development, manufacture and sale of a range of pharmaceutical products for humans and animals. Pfizer is active in the production of vaccines for animals. The operation was examined under the simplified merger review procedure.
Eli Lilly is a research based, global pharmaceutical company engaged in the discovery, development, manufacture and sale of a range of pharmaceutical products for humans and animals. Pfizer is active in the production of vaccines for animals. The operation was examined under the simplified merger review procedure.